Skip to content

RNTX RNTX Net Income

Net Income at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$2.68B+9.0%
Gilead Sciences logo
Gilead SciencesGILD
$2.02B+53.7%
AbbVie logo
AbbVieABBV
$695M-46.0%
CTO
Citius Oncology, Inc.CTOR
-$26.61M-244%
Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
-$10.79M+27.5%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
-$8.69M-422%

Other financials

Income statement

See full
Revenue-
Operating income-$5.2M+6.8%
EPS (diluted)-$0.19+24.0%

Balance sheet

See full
Cash & equivalents$4.4M-40.2%
Total debt$48.0K0.0%
Total equity$6.9M-63.0%
Total assets$26.3M-54.4%

Cash flow

See full
Operating cash flow-$3.4M+44.6%
CapEx-
Free cash flow-$6.3M

Valuation

See full
Market cap$88.96M+177%

Returns & leverage

See full
Return on equity-123.3%+86.1pp
Debt / equity0.0×
Current ratio0.4×-1.0×

Where this comes from

Reported directly by RNTX in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: RNTX’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about RNTX's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RNTX's net income?
RNTX (RNTX) reported net income of -$5.84M in Q1 2026.
How has RNTX's net income changed year-over-year?
RNTX's net income decreased by 6.1% year-over-year, from -$5.5M to -$5.84M.
What is the long-term trend for RNTX's net income?
Over 4 years (2021 to 2025), RNTX's net income has grown at a 17.5% compound annual growth rate (CAGR), from -$26.16M to -$49.87M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.